CARDIAC DIAGNOSTIC REPORT
=========================
Patient:    Ivan P., Male, 55 years old
Date:       February 20, 2026
Facility:   Cardiovascular Diagnostic Center, Sofia
Physician:  Dr. M. Georgieva, MD Cardiology

────────────────────────────────────────────────────────────────────
1. REASON FOR EXAMINATION
────────────────────────────────────────────────────────────────────
Periodic checkup requested by patient due to:
  - Occasional shortness of breath during moderate exertion (climbing 2 floors)
  - Two episodes of palpitations in the last 3 months, each lasting ~10 minutes
  - Family history: father had MI at age 62
  - Patient is a moderate smoker (15 cigarettes/day for 25 years)
  - Sedentary lifestyle, desk work

────────────────────────────────────────────────────────────────────
2. CLINICAL MEASUREMENTS
────────────────────────────────────────────────────────────────────
Blood Pressure:    148/92 mmHg  (Grade 2 hypertension — Stage 1 elevated)
Resting Heart Rate: 78 bpm  (normal range)
BMI:               27.4  (slightly overweight)
SpO2 at rest:      97%   (normal)
SpO2 after treadmill stress (7 min, moderate): 94%  (borderline drop)

────────────────────────────────────────────────────────────────────
3. ECG — 12-LEAD ELECTROCARDIOGRAM
────────────────────────────────────────────────────────────────────
Rhythm:          Sinus rhythm
QRS Duration:    98 ms (normal <120 ms)
QTc Interval:    438 ms (normal <450 ms)
PR Interval:     184 ms (upper normal, borderline first-degree AV block)
ST segment:      Mild ST depression 0.8 mm in leads V4-V5 during stress test
                 (returns to baseline within 3 min of recovery)
Left axis deviation: minimal, not clinically significant
Findings: Possible early ischemic changes under stress in the lateral wall.
          Occasional premature atrial contractions (PAC) — 3 per hour at rest.

────────────────────────────────────────────────────────────────────
4. ECHOCARDIOGRAM (TRANSTHORACIC)
────────────────────────────────────────────────────────────────────
Left Ventricular Ejection Fraction (LVEF): 54%
  (Normal: ≥55%; borderline mildly reduced)
Left Ventricular End-Diastolic Diameter (LVEDD): 56 mm
  (Normal male: 42-59 mm — upper end of normal)
Left Ventricular Wall Thickness (Interventricular Septum): 12.5 mm
  (Normal: <11 mm → MILD concentric LV hypertrophy — likely hypertension-related)
Left Atrial Diameter: 43 mm (Normal <40 mm → mildly dilated)
Mitral Valve: Trace mitral regurgitation, leaflets structurally normal
Aortic Valve: Tricuspid, no stenosis, minimal calcification at leaflet tips
Diastolic Dysfunction: Grade 1 (impaired relaxation pattern — E/A ratio 0.85)
Pericardium: No effusion
Wall Motion: Normal at rest; anterolateral hypokinesia noted at peak stress

────────────────────────────────────────────────────────────────────
5. LABORATORY RESULTS
────────────────────────────────────────────────────────────────────
Total Cholesterol:   6.8 mmol/L  (HIGH — normal <5.2)
LDL Cholesterol:     4.1 mmol/L  (HIGH — target <2.6 for cardiac risk)
HDL Cholesterol:     1.1 mmol/L  (borderline low — target >1.0 for men)
Triglycerides:       2.4 mmol/L  (ELEVATED — normal <1.7)
HbA1c:               5.9%        (prediabetes range — normal <5.7%)
Fasting Glucose:     6.1 mmol/L  (prediabetes — normal <5.6)
hsCRP (inflammation):1.8 mg/L    (borderline — normal <1.0 is low risk)
Troponin I:          <0.01 ng/mL (NORMAL — no acute myocardial injury)
BNP (heart failure): 78 pg/mL    (ELEVATED — normal <35 pg/mL → compensated stress)
Creatinine:          94 μmol/L   (normal renal function)
TSH:                 2.1 mIU/L   (normal thyroid)

────────────────────────────────────────────────────────────────────
6. CORONARY ARTERY CALCIUM SCORE (CT)
────────────────────────────────────────────────────────────────────
Total CAC Score: 127 (Agatston units)
  LAD (Left Anterior Descending): 89 units  (moderate calcification)
  LCX (Left Circumflex):          21 units  (mild)
  RCA (Right Coronary Artery):    17 units  (mild)
Interpretation: Score 100-400 = MODERATE cardiovascular risk.
  Corresponds to approximately 10-year MACE risk of 10-15% (Framingham).

────────────────────────────────────────────────────────────────────
7. CURRENT MEDICATIONS
────────────────────────────────────────────────────────────────────
  - Amlodipine 5mg/day  (calcium channel blocker for hypertension)
  - Aspirin 100mg/day   (antiplatelet, started last year)
  - No statin currently prescribed (newly indicated based on today's labs)

────────────────────────────────────────────────────────────────────
8. PHYSICIAN ASSESSMENT & CONCLUSIONS
────────────────────────────────────────────────────────────────────
PRIMARY FINDINGS:
  1. Borderline reduced LVEF (54%) with mild LV hypertrophy — early cardiac
     remodeling in the context of uncontrolled hypertension.
  2. Grade 1 diastolic dysfunction — the heart is losing elasticity/compliance.
  3. Mildly dilated left atrium — increased AF risk over next 5-10 years.
  4. Stress-induced anterolateral hypokinesia — suggests reduced perfusion
     in the LAD territory correlating with CAC score of 89 in LAD.
  5. Elevated cardiovascular risk profile: dyslipidemia + prediabetes +
     hypertension + smoking + positive family history + elevated CAC.
  6. BNP 78 pg/mL suggests the heart is under increased workload stress,
     compensated but not optimal.

RISK STRATIFICATION:
  - 10-year cardiovascular event risk (SCORE2): approximately 12-15% (HIGH)
  - AF lifetime risk: elevated due to LA dilation + hypertension

RECOMMENDED INTERVENTIONS:
  1. Initiate Rosuvastatin 20mg/day (target LDL <1.8 mmol/L in high risk)
  2. Intensify blood pressure control — add ACE inhibitor (Perindopril 5mg)
     (also provides renal and cardiac protective effects)
  3. Lifestyle: smoking cessation MANDATORY — quantified risk increase 2.5x
  4. Mediterranean diet + moderate aerobic exercise 150 min/week
  5. Glucose monitoring — HbA1c follow-up in 3 months; metformin if progresses
  6. Follow-up echocardiogram in 6 months to track LVEF and diastolic function
  7. Holter monitor 24h to quantify PAC burden and rule out paroxysmal AF

PROGNOSIS WITH COMPLIANCE:
  With full medication compliance, smoking cessation, and lifestyle changes:
  LVEF expected to recover to 56-60% within 12 months.
  10-year MACE risk reducible to ~6-8%.

PROGNOSIS WITHOUT COMPLIANCE:
  Progressive LV remodeling, LA dilation → AF, increased MI risk within 5-7 years.

────────────────────────────────────────────────────────────────────
9. PATIENT REPORTED SYMPTOMS (SUBJECTIVE)
────────────────────────────────────────────────────────────────────
  - "I feel mostly fine but get winded faster than 5 years ago"
  - Palpitation episodes not associated with chest pain or syncope
  - Sleep quality: moderate (snoring, not assessed for OSA)
  - Stress level: HIGH (management position, 55-60h work week)
  - Exercise: minimal (walk ~20 min 2-3x/week)
  - Diet: high in processed food, red meat, low in vegetables
  - Alcohol: 2-3 glasses of wine per week (moderate)

────────────────────────────────────────────────────────────────────
END OF REPORT
────────────────────────────────────────────────────────────────────
